Clinical validation of the CE-IVD marked Therascreen MGMT kit in a cohort of glioblastoma patients
Véronique Quillien,
Audrey Lavenu,
François Ducray,
David Meyronet,
Olivier Chinot,
Frédéric Fina,
Marc Sanson,
Catherine Carpentier,
Lucie Karayan-Tapon,
Pierre Rivet,
others
January, 2017